Bromsite (Bromfenac Sodium) Patent Expiration, LOE Window & CMS Spending

Bromsite (Bromfenac Sodium) by Sun Pharmaceutical: FDA Orange Book LOE 2029-03-05, 5 AB generics, $1.4M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSun Pharmaceutical
FDA Application & PathwayN206911 (NDA)
Exclusivity / Cliff HorizonNear-Term Cliff (2028-2030)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2029-03-05
Orange Book Patents (*PED Extensions)1 patents (0 *PED)
Active AB-Rated Generic Competitors5
2024 CMS Total Public Spend$1.4M
2024 Medicare Part D Spend$1.4M
2024 Medicaid Spend$35K
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel